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ABSTRACT Reconstruction of genome-scale metabolic networks is now possible using multiple different data types.
Constraint-based modeling is an approach to interrogate capabilities of reconstructed networks by constraining possible cellular
behavior through the imposition of physicochemical laws. As a result, a steady-state ﬂux space is deﬁned that contains all
possible functional states of the network. Uniform random sampling of the steady-state ﬂux space allows for the unbiased
appraisal of its contents. Monte Carlo sampling of the steady-state ﬂux space of the reconstructed human red blood cell
metabolic network under simulated physiologic conditions yielded the following key results: 1), probability distributions for the
values of individual metabolic ﬂuxes showed a wide variety of shapes that could not have been inferred without computation; 2),
pairwise correlation coefﬁcients were calculated between all ﬂuxes, determining the level of independence between the
measurement of any two ﬂuxes, and identifying highly correlated reaction sets; and 3), the network-wide effects of the change in
one (or a few) variables (i.e., a simulated enzymopathy or ﬁxing a ﬂux range based on measurements) were computed.
Mathematical models provide the most compact and informative representation of a hypothesis of how a cell works. Thus,
understanding model predictions clearly is vital to driving forward the iterative model-building procedure that is at the heart of
systems biology. Taken together, the Monte Carlo sampling procedure provides a broadening of the constraint-based approach
by allowing for the unbiased and detailed assessment of the impact of the applied physicochemical constraints on a
reconstructed network.
INTRODUCTION
Genome-scale models provide a comprehensive, yet concise
representation of biological reaction networks and their
functional states (Price et al., 2003a). A growing number of
genome-scale reconstructed networks for the model (Famili
et al., 2003; Reed and Palsson, 2003; Reed et al., 2003) and
infectious (Edwards and Palsson, 1999; Schilling et al., 2002)
microorganisms are becoming available. At this scale, it has
proven difﬁcult to formulate kinetic models, which have
proven to be useful on a small scale (Hasty et al., 2002, 2001)
and thus different modeling approaches are needed. One such
approach is the constraint-based modeling approach. This
approach uses the constraints imposed on network functions
by identiﬁable physicochemical laws to form a solution space
which contains all candidate steady-state solutions (Covert
et al., 2004; Price et al., 2003a). Previous constraint-based
modeling studies have focused on identifying optimal states in
steady-state ﬂux spaces (Edwards et al., 2002), potential
cellular objectives (Burgard and Maranas, 2003), minimal
necessary reaction (or gene) sets (Burgard et al., 2001), and
upon enumerating the extreme pathways (Papin et al., 2003;
Schilling and Palsson, 2000) (convex basis vectors) or
elementary modes (Schuster et al., 2000; Schuster and
Hilgetag, 1994) of the solution space. Constraint-based
modeling has proven valuable in predicting phenotypes such
as optimal growth rates (Edwards et al., 2001), lethality of
gene knockouts (Edwards and Palsson, 2000; Forster et al.,
2003), effects of gene additions and deletions (Burgard and
Maranas, 2001; Segre et al., 2002), and the endpoint of an
adaptive evolution (Ibarra et al., 2002).
A recently developed dimension within the constraint-
based modeling approach is uniform random sampling of the
steady-state ﬂux space (Almaas et al., 2004; Wiback et al.,
2004). This approach is used to fully determine the range of
possible steady-state ﬂuxes allowed in the network under
deﬁned physicochemical constraints. A Monte Carlo sam-
pling procedure was applied to the metabolic network of the
human red blood cell, the modeling of which has reached an
advanced state (Jamshidi et al., 2001; Kauffman et al., 2002;
Lew and Bookchin, 1986; Mulquiney et al., 1999;
Mulquiney and Kuchel, 1999, 2003; Price et al., 2003b;
Schuster and Holzhutter, 1995; Schuster et al., 1988; Wiback
and Palsson, 2002). Monte Carlo sampling has also proven
very useful in analyzing the general properties of networks
by testing their robustness to parameter variation (Alves and
Savageau, 2000a,b,c). The approach utilized herein has the
utility to identify the selection of independent measurements
to determine the state of a biochemical network and to
predict systemic effects from the reduction in a maximal
reaction rate to simulate enzymopathies.
MATERIALS AND METHODS
Problem overview
The objectives of the Monte Carlo sampling procedure are: 1), to generate
uniform random samples of points in the steady-state ﬂux space and 2), to
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calculate the hypervolume of this space. To accomplish these objectives the
steady-state ﬂux solution space is enclosed by a geometric object in which
uniformly distributed random points can be readily generated and that has an
easily-calculable volume. Importantly, the shape of the chosen object needs
to ﬁt as tightly as possible around the steady-state ﬂux space to have a high
fraction of points that are in the geometric object and in the steady-state ﬂux
space. A parallelepiped with the same dimension as the rank, r, of the null
space of S, is an object that meets these criteria. The parallelepiped is
represented as a matrix, B, where each column of B represents a set of
spanning edges of the parallelepiped,
B ¼
j j j
b1 . . . bi . . . br
j j j
0
@
1
A: (1)
The volume of a parallelepiped is simple to compute (Meyer, 2000),
Volume ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
detðBTBÞ
q
; (2)
where the columns of B are the axes of the enclosing parallelepiped. Uniform
random samples can be generated within a parallelepiped simply by
generating uniform random weightings on all of the spanning edges between
the minimum and maximum allowed values and picking the point inside the
space based on the weightings, ai, generated on each of the basis vectors, bi,
as
v ¼ +
i
aibi; ai;min#ai#ai;max; (3)
where v is a point within the space deﬁned by summing the weightings on
each of the basis vectors between the minimum and maximum values
allowable in the bounding parallelepiped. The Monte Carlo sampling
procedure was applied to a simple ﬂux split to illustrate how this approach
works (Fig. 1).
Imposition of constraints: deﬁning the
steady-state ﬂux space
The imposition of constraints based on physicochemical principles deﬁnes
the steady-state ﬂux space. At steady state, a simultaneous mass balance on
all compounds in the network requires that (Bonarius et al., 1997; Schilling
et al., 1999)
S  v ¼ 0; (4)
where S is the stoichiometric matrix representing all known reactions in the
network and v is the ﬂux vector describing the ﬂux through each of these
reactions. All solutions to Eq. 4 lie in the null space of S (Fig. 1 B).
The next sets of constraints used to deﬁne the steady-state solution space
are minimum and maximum ﬂux rates through each of the reactions,
V
i
min# vi#V
i
max; (5)
where the ﬂux, vi, through each reaction i, must lie between the V
i
min and the
V imax for that reaction. These V
i
max and V
i
min constraints thus segment the null
space deﬁned by Eq. 4 (Fig. 1 B).
In this article, the elementary forward and reverse reactions are combined
into a net reaction. Reactions can thus have a negative V imin to indicate that
the reaction is being used in the direction opposite to that deﬁned as positive
in S. The V imax values are generally based on experimental measurements.
For irreversible reactions, the V imin values are set to zero, and for reversible
reactions the V imin is set to V imax.
Elimination of redundant constraints
Many reaction V imax levels cannot be reached in a steady state because the
saturation of other reactions is more constraining upon the reaction ﬂux, vi,
than its own saturation state. Thus, many of the V imax constraints are
redundant from a systems point of view, and do not affect the size of the
solution space. Redundant V imax and V
i
min constraints that were not needed to
deﬁne the steady-state ﬂux space (i.e., these redundant constraints lay
outside of more constraining V imax and V
i
min constraints) were eliminated and
not needed for the generation of the sample points.
Choice of enclosing parallelepiped
Because each pair of V imax and V
i
min constraints form parallel hyperplanes,
the shape of the null space leads naturally to the choice of a high-
dimensional parallelepiped in which to enclose it. The set of possible
parallelepipeds that could be used to enclose the steady-state ﬂux space was
chosen by forming the faces of the parallelepiped along the directions
deﬁned by these V imax and V
i
min constraints. Since each parallelepiped is
deﬁned by r planes which are chosen from the set of m V imax and V
i
min
planes, the number of such parallelepipeds that could be used enclose the
space is
Number of possible parallelepipeds ¼ m
r
 
¼ m!
r!ðm rÞ!;
(6)
where m is the number of Vmax constraints and r is the dimension of the null
space (see Fig. 1 C).
Minimizing the volume of the
enclosing parallelepiped
Checking the volume of every possible parallelepiped to ﬁnd the smallest
can become prohibitive due to the large number of parallelepipeds (i.e., Eq.
6). Therefore, an alternate approach was used. This algorithm chooses its
ﬁrst direction based on the set of V imax and V
i
min constraints that are the
closest together based on Euclidian distance. Then, the next direction is
chosen by determining the smallest parallelogram that can be formed by
choosing the next set of V imax and V
i
min constraints. The third direction is
chosen as the set of constraints that forms the smallest parallelepiped formed
using three sets of V imax and V
i
min constraints and so on until the
parallelepiped fully encloses the solution space (Fig. 1 D).
Uniform random sampling of points
Uniform random points were generated within the solution space by
randomly sampling within the enclosing parallelepiped. Randomly sampling
within the parallelepiped was accomplished by uniformly sampling along
each of the edges, bi, deﬁning the parallelepiped and picking the point
resulting from the sum of this set of weightings. Each point in the space is
uniquely deﬁned by weightings on the edges spanning the parallelepiped
(Eq. 3). The weighting, ai, on each basis vector, bi, was uniformly selected
by generating a pseudo-random number, f, between 0 and 1 and then
assigning each weight as
ai ¼ ai;min1 f3Li; (7)
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where L is the length of the corresponding edge, bi, in the parallelepiped.
Points generated uniformly within the parallelepiped were then compared to
the set of V imax and V
i
min constraints to verify whether the point falls in the
solution space or not. If the point satisﬁes all constraints, it is a valid solution
and is kept in the set. If the randomly generated point does not satisfy all the
necessary constraints, it is excluded. The fraction of total points generated
that fall within the space, the ‘‘hit’’ fraction, was used to calculate the
absolute volume of the steady-state ﬂux space (see Fig. 1 D).
Volume calculation of steady-state ﬂux space
The volume of the steady-state ﬂux space can be calculated by multiplying
the volume of the enclosing parallelepiped by the fraction of generated
points that falls within the solution space
Estimated volume of solution space
 Hit fraction3Volume of parallelepiped: (8)
The estimated relative error in the volume calculation obtained through the
Monte Carlo sampling procedure decreases as the number of points sampled
increases. The variance of the estimate, s2, is given as
s
2 ¼ p^ð1 p^Þ
n
#
1
4n
; (9)
where pˆ is the ratio of sampled points that fall inside the solution space (hit
fraction) and n is the total number of sample points generated. The relative
error of the hit fraction estimate, e, is calculated as the ratio of the standard
deviation, s, to the mean, m,
e ¼ s
m
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p^
1  1
N
s
; (10)
showing that the estimate improves with increasing sample size, N, as well
as a higher hit fraction, pˆ, as would be expected.
FIGURE 1 Algorithm for boxing in solution
space with parallelepiped and generating uni-
form random samples. A simple ﬂux split was
used as an example to demonstrate how the
Monte Carlo sampling procedure works (A).
The two-dimensional null space is constrained
by the Vmax planes corresponding to the three
reactions in the network (B). Once the null
space is capped off by the reaction Vmax values,
combinations choosing two of the three sets of
parallel constraints leads to forming three
potential parallelepipeds (C). The smallest of
these parallelepipeds is chosen and uniform
random points within the parallelepiped are
generated (D) based on uniform weightings on
the basis vectors deﬁning the parallelepiped
(shown as black arrows). Points within the
solution space are kept and those that fall out of
the solution space are discarded. The fraction of
the points generated inside the parallelepiped
that fall within the solution space is called the
‘‘hit fraction.’’ The hit fraction multiplied by
the volume of the parallelepiped yields the
volume of the solution space. Probability
distributions for each of the three ﬂuxes are
calculated from the set of points within the
solution space (D).
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Red blood cell metabolic network
The red blood cell metabolic network used in this study consists of 48
reactions utilizing 39 metabolites. Reversible reactions were not decoupled
into forward and reverse reactions, and thus were allowed to take on negative
values as discussed above. The dimension of the null space of this
stoichiometric matrix was 11. This red blood cell network differs slightly
from the one previously used to study extreme pathways (Wiback and
Palsson, 2002) in that the metabolic loads are represented as turnover
reactions, rather than as exchange ﬂuxes and also differs from the network
studied in Wiback et al. (2004) in that it contains reversible reactions. The
V imax values utilized in this studywere taken fromWiback and Palsson (2002),
with the V imax of all reactions without a stated V
i
max in Wiback and Palsson
(2002) being set at an arbitrarily high value of 1000 so that none of these
reactions was limiting on the system. Thus, all reaction ﬂuxes were limited by
either a measured V imax value or an uptake rate. The V
i
min values were set to
V imin for reversible reactions and to zero for all irreversible reactions, unless
there was a minimum physiological demand, as detailed in the next section.
Physiologic conditions
In addition to limitations on ﬂux values due to V imax values, certain known
physiologic demands were used to identify the range of potential ﬂux values.
For example, the red blood cell is obligated to produce a basal level of ATP to
run the sodium potassium pump to balance against the natural diffusion rate of
sodium and potassium that ‘‘leaks’’ through the membrane. Thus, the
minimum ATP production rate in this study was set to 1 mM/h to reﬂect this
fact. The maximum ATP production rate was set at 1.5, as a conservative
bound, higher than themaximumvalueobserved in awide range of calculations
based on a full-scale kinetic model (Jamshidi et al., 2001). Also, a minimal
amount of NADH production is necessary to convert Met-hemoglobin into its
functional state. The minimum NADH production rate was set to 0.4 mM/h
based on the oxidation rate of iron in hemoglobin. This minimal level of
NADPHproduction was set to 0.05mM/h for the turnover of GSSG toGSH to
combat a minimal level of reactive oxygen species. Lastly, the minimum ﬂux
through DPGase was set to 0.3 mM/h, since this ﬂux always operates near
saturation levels because of the high intracellular concentration of 23DPG and
the slow rate of this reaction (time constant on the order of half a day).
Convergence of statistics with
increasing samples
To determine that sufﬁciently large samples were taken to accurately assess
each of the statistical properties computed, samples were taken until the
statistics being assessed ceased changing with increased sample size relative
to the error deemed appropriate for the property being calculated. At the
sample sizes used in this study, completely new sets of random samples were
also taken with the results remaining unchanged for the signiﬁcant ﬁgures
related, and this resampling was done numerous times. Thus, as should be
the case, all results presented herein are independent of the particular set of
uniform random samples used, and are generic properties of the metabolic
solution space. Speciﬁc details on the number of repetitions and the size of
the samples are given along with each of the calculated results in the ﬁgure
captions.
Computation and implementation
Computations for this study were performed on Dell Workstations (either
a Dell Precision 340 or Dimension 8200) or on a Linux box (Dual Athlon
MP 2400, 2 GB RAM). The program for ﬁnding the enclosing
parallelepiped and for generating points was performed using MATLAB
(The MathWorks, Natick, MA) and an interface with the linear pro-
gramming package LINDO API (Lindo Systems, Chicago, IL). As an
indication of the efﬁciency of the calculations, the computation of 250,000
uniform random samples within the red blood cell steady-state ﬂux space
using the Dell workstations was performed in ,30 s. The calculation of
1,000,000 points inside the steady-state ﬂux space was performed on the
Linux box in ,50 s. The approach herein was very fast compared to the
previous sampling approach used in Wiback et al. (2004), which describes
the calculation of 250,000 uniform points in the red blood cell metabolic
network as taking ‘‘over a week’’ of calculation (Dell Dimension 8200).
Thus, the approach presented herein represents an ;20,000-fold increase in
calculation efﬁciency over the approach used in Wiback et al. (2004).
Increased sampling efﬁciency is important because it allows for more
detailed and precise calculations, increased capacity to study improbable
regions of the steady-state ﬂux space, and better error assessment.
RESULTS
Uniform random samples were generated within the steady-
state ﬂux space of the in silico model of human red blood cell
metabolism. The set of candidate solutions can then be
further segmented based on additional criteria. The results
herein demonstrate how this approach can be used to 1),
provide all possible steady-state distributions for unknown
metabolic ﬂuxes; 2), guide making informative experimental
measurements; and 3), study the systemwide effects of an
enzymopathy through lowered enzyme activity.
Distribution of ﬂux values and
space segmentation
The set of candidate steady-state ﬂux distributions through
each reaction in the red blood cell metabolic network were
represented as a histogram of all possible ﬂux values and
displayed on the metabolic map (Fig. 2). Each histogram
presents one-dimensional information on its x axis, in terms
of the extent of possible values for that particular ﬂux. The
y axis represents the ‘‘size’’ of space in the other r–1
dimensions resulting from slicing the metabolic solution
space along a speciﬁc value of the ﬂux through the indicated
reaction. Thus the ‘‘height’’ of each histogram represents
r–1 dimensional data (see illustration in Fig. 1 D).
The histograms of steady-state ﬂux values can be roughly
classiﬁed into four groups based on their shape:
1. Left peak, the lowest allowable ﬂux value through the
reaction is the most probable, such as the ﬂuxes through
AK and AMPase.
2. Right peak, the highest allowable ﬂux value is most
probable such as the ﬂux through reaction HK.
3. Central peak, a point in between the V imax and V
i
min is the
most probable with the upper and lower possible ﬂux
values approaching a zero probability, such as the ﬂuxes
through reactions PFK, PK, and LD.
4. Broad peak, a plateau of equally probable ﬂux values
exists, such as the ﬂuxes through NADH load and PYR
uptake.
Histograms for reactions that do not contain a zero ﬂux
value are essential under the conditions examined. None of
these histograms can have more than one peak due to the
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convexity of the steady-state ﬂux space. The shape of these
histograms is highly informative about how a reduction in
the allowable range of each ﬂux would affect the remaining
size of the steady-state ﬂux space. The percentage of the
histogram area remaining in the reduced range is the same as
the percentage of the remaining steady-state ﬂux space.
Correlation of ﬂux measurements: use in
designing experiments
Uniform random sampling of the steady-state ﬂux space
allows for the calculation of the correlation coefﬁcient (rij)
between any two ﬂuxes (vi and vj) in the network. Thus,
sampling provides a straightforward means of not only
calculating perfectly correlated subsets (r2ij ¼ 1), but also of
identifying well-correlated, but not perfectly correlated
reaction sets. The matrix of squared pairwise correlation
coefﬁcients for all the RBC metabolic ﬂuxes was computed.
The ﬂuxes can be ordered such that the ‘‘correlated reaction
sets’’ (deﬁned here as rij
2 . 0.99) are listed in order of
decreasing number of ﬂuxes in each set (Table 1).
The identiﬁcation of the correlated reaction sets can help
guide experimental design. The measurement of any ﬂux in
a perfectly correlated reaction set determines the steady-state
ﬂux level through all reactions in a set. Therefore, making
a measurement of one ﬂux in the largest correlated set,
FIGURE 2 Probability ﬂux distributions for human red blood cell. The red blood cell model with imposed maximum and minimum constraints on each ﬂux
was sampled using the in silico algorithm. The histograms next to each reaction represent the distribution of solutions with respect to each reaction ﬂux. The
vertical shaded line on each plot indicates where the zero ﬂux line is. Several general ﬂux distribution patterns have been identiﬁed including right peak (HK),
left peak (G6PDH), central peak (PGK), and broad peak (PYR exchange). Due to the convexity of the solution space, no distribution can have more than one
peak. The ﬂux distribution shape gives information about the sensitivity of the solution space to each constraint. If a ﬂux distribution has a right peak,
decreasing a maximum constraint will eliminate many solutions from the valid space. Reactions that are part of the same pathway with no intermediate branch
points (PGM, EM, PK) all have the same ﬂux distributions. Distributions shown are based on 500,000 uniformly distributed points in the steady-state ﬂux
space. These details on these distributions can be seen in more detail in Fig. 3 (original distributions). The dotted lines in the load reactions represent the main
physiologic function of the speciﬁed metabolic load, but are not explicitly accounted for in the stoichiometric matrix.
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TABLE 1 Correlation between ﬂux values in the solution space
Correlations were calculated between pairs of reactions in the red blood cell model using 250,000 randomly sampled points. This is used to quantify the degree of similarity between reactions. Perfect
correlation (1.00) is exhibited between reactions on the same linear pathway (TK1, TK2, TA, Xu5PE). The correlation coefﬁcients were calculated using 1,000,000 uniform points within the steady-state ﬂux
space. The calculation of this correlation matrix was performed three separate times with 1,000,000 points each and the maximum difference between any calculated squared correlation coefﬁcients was 0.002.
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consisting of reactions in the pentose phosphate pathway,
essentially determines the steady-state ﬂux distribution
through each of the nine reactions in the correlated set. In
addition, four other ﬂuxes would also be largely determined,
with correlation coefﬁcients.0.88. The same is true with the
measurement of any ﬂux in a correlated set.
A second important factor to consider when choosing
ﬂuxes for measurement to best determine the ﬂux state of the
red blood cell is to measure a set of ﬂuxes that are
uncorrelated to each other (r2ij values close to zero). Such a set
ensures that the ﬂux measurements are not providing
duplicate information. Thus, by iteratively choosing to
measure ﬂuxes that are uncorrelated to each other and to
what has already been measured, the correlation matrix
guides the selection of independent ﬂux measurements.
A third factor that determines how informative an
experimental measurement will be is where in the solution
space the measurement falls. For example, if a ﬂux
measurement falls in an improbable region of the histogram,
it will be much more constraining for determining the ﬂux
state of the system than a measurement taken in a probable
region. The numerical range of ﬂux measurement is
generally unknown before the measurement is taken, and
thus the reduction in the size of the solution space is known
only after the experimental measurement is taken. However,
this information can be taken into account using previous
experience and intuition to evaluate if a ﬂux measurement is
likely to occur in a region deemed improbable by, and thus
highly informative to, the current status of the model.
Thus, the Monte Carlo sampling procedure provides three
important criteria for designing a set of informative
measurements to determine the state of the system:
1. How correlated is a measured ﬂux to unknown ﬂuxes?
2. Is the measured ﬂux uncorrelated to the information
already known?
3. Is there any basis for expecting that a ﬂux measurement
will fall in an improbable region of the ﬂux histogram?
In this manner, the correlation matrix, generated by taking
uniform random samples of points in the steady-state ﬂux
space, guides which ﬂux measurements will likely provide
the most information about the network. Once informative
ﬂux measurements are made, the sampling procedure can
then be used to ﬁll in all possible steady-state ﬂuxes through
all the remaining unmeasured ﬂuxes in the network that are
in agreement with the experimental data.
Systemic effects of simulated enzymopathies
The sampling procedure can be used to track the network-
wide changes that occur due to changes to a single, or a small
number, of individual reactions. For example, a substantial
number of single nucleotide polymorphisms (SNPs) have
been found in genes of red blood cell enzymes, which
signiﬁcantly decrease the V imax values through many
reactions in the red blood cell (Jacobasch and Rapoport,
1996; Tanaka and Zerez, 1990). Some of these SNPs have
been correlated to chronic and nonchronic anemia (Grimes,
1980; Thorburn and Kuchel, 1985) and the systemic effects
of the two most common SNPs in the red blood cell,
pyruvate kinase (PK) and glucose-6-phosphate dehydroge-
nase (G6PDH), have recently been evaluated using a kinetic
model of red cell metabolism (Jamshidi et al., 2002).
Defects in glycolytic enzymes were simulated to demon-
strate how a 75% reduction in their normal operating range
(though a decreased V imax) would affect the network. For
each reaction, an enzymopathy was simulated by setting a
reduced maximum ﬂux for the reaction, V imax;restricted, as
V
i
max;restricted ¼ V imin;effective1
V
i
min;effective  V imax;effective
4
; (11)
where V imax;effective and V
i
min;effective were the maximum and
minimum ﬂux values achievable in the unaltered system.
The percentage of the steady-state ﬂux space remaining after
restricting each of these reactions to one-quarter their normal
operating range is shown in Table 2. As discussed above, the
shape of the ﬂux histograms, shown in Fig. 2, are a means for
immediately determining the impact of a reduction in the
allowable range of any ﬂux. Such impact can be evaluated by
comparing the reduction in the size of the steady-state ﬂux
space seen in Table 2 with the histograms shown in Fig. 2. A
reduction in the V imax of a reaction that has a right peak
distribution will reduce the size of the steady-state ﬂux space
more than a reduction in the V imax of a reaction with a left
peak distribution.
The restriction of one reaction ﬂux, such as occurs with an
enzymopathy, can have a profound effect on the behavior of
the network as a whole, affecting the functioning of many
other reactions. Results from a simulated enzymopathy
through the PK reaction, the most common enzymopathy in
the glycolytic pathway (Tanaka and Zerez, 1990), are shown
as an example.
The V imax through PK was reduced such that the allowable
ﬂux range is decreased ﬁrst to one-half and then to one-
quarter of the original range. The systemic effects of the
simulated enzymopathy through the PK reaction greatly
affected the probability distributions through many reactions
in the red blood cell metabolic network (Fig. 3). For
example, the probability distribution for glucose uptake
changed from being a right peak distribution to being a
central peak distribution, meaning that its normal operating
range in the red blood cell changed from being in its most
probable region to being in an improbable operating region
of the steady-state ﬂux space. With the PK range constrained
to one-quarter of the original range, the maximum possible
value for glucose uptake also decreased, making the previous
upper range impossible to the network.
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Constraining the range of allowable PK values to one-
quarter of the original range signiﬁcantly changed the
correlations between many metabolic ﬂuxes (Table 3). For
example, the correlation between glucose uptake and the ﬂux
through the pentose phosphate pathway increased dramati-
cally, with the r2 value between HK and G6PDH increasing
by 0.79. This change in correlation is due to the limitation on
the steady-state ﬂux allowable through glycolysis due to the
decreased capacity of PK. The increase in the correlation
between two ﬂuxes can be seen in the example of G6PDH
versus HK and GAPDH versus TPI (Fig. 4). A high
correlation coefﬁcient implies that the shape of the two-
dimensional histogram will be narrow, whereas a low
correlation coefﬁcient implies that the two-dimensional
histogram will be broad. In the case of G6PDH versus HK,
the PK enzymopathy causes the r2 value to increase
signiﬁcantly. In the case of GAPDH versus TPI, the r2
value decreases signiﬁcantly with the simulated PK
enzymopathy. Also of interest, the direction of the ridge
representing the most probable values with the simulated PK
enzymopathy changes direction signiﬁcantly compared to
the dominant direction of the correlation without the PK
enzymopathy.
DISCUSSION
Uniform random sampling of a constrained steady-state ﬂux
space allows for an unbiased appraisal of the effects of the
imposed physicochemical constraints on the possible
functional states of a reconstructed metabolic network. The
computation and analysis of uniform random points for the
metabolic network of the red blood cell under the conditions
of its nominal physiologic demands yielded the following
key results:
1. Probability distributions were computed for ﬂuxes
through all reactions, characterizing the feasible steady-
state ﬂux space.
2. Pairwise correlation coefﬁcients were calculated between
all ﬂuxes, determining the level of independence between
any two ﬂuxes, and identifying highly correlated reaction
sets.
3. The systemwide effects of the change in one (or a few)
variables (i.e., a simulated enzymopathy or setting a ﬂux
range based on measurements of physiological consid-
erations) were computed, showing that not only do
the ranges of allowed ﬂux values change throughout the
network, but also their probability distributions and
the correlations between metabolic ﬂuxes.
Uniform random samples were used to calculate probability
distributions for every ﬂux in the red blood cell metabolic
network. These probability distributions help to quantify the
nature of all possible network ﬂux states that satisfy the
applied constraints, physiological demands, and experimen-
tal data without any additional assumptions (such as optimal
behavior), and create a framework in which to place
experimental results in the context of total network
capabilities. The shape of the distributions are highly
informative about:
1. The impact a lower V imax will have on the size of the
steady-state ﬂux space, and thus on how constraining to
the system a reduced ﬂux capacity through a speciﬁc
reaction would be.
2. The reduction in the steady-state ﬂux space based on
additional experimental measurements.
TABLE 2 Effects of simulated enzymopathies in glycolytic enzymes on steady-state ﬂux space
Glycolytic enzymes V imax Constraining?
Systemic
V imax
Systemic
V imin
Restricted
V imax
Percentage of steady-state
ﬂux space remaining
Hemolytic
anemia?*
Hexokinase (HK) 1.5 Yes 1.50 0.48 0.74 0.02% Yes
Phosphofructokinase (PFK) 250 No 1.58 0.31 0.63 0.21% Variable
Triose phosphate
isomerase (TPI)
1000 No 1.58 0.31 0.63 0.21% Yes
Aldolase (ALD) 1000 No 1.58 0.31 0.63 0.21% Yes
Lactate dehydrogenase (LDH) 1000 No 2.81 0.09 0.77 0.56% No
Pyruvate kinase (PK) 250 No 3.21 1.17 1.68 0.83% Yes
Enolase (EN) 1000 No 3.21 1.17 1.68 0.84% Yes
Phosphoglucoisomerase (PGI) 1000 No 1.48 0.77 0.21 1.0% Yes
Phosphoglycerate kinase (PGK) 1000 No 2.91 0.87 1.38 2.2% Usually
Diphosphoglycerate
phosphatase (DPGase)
0.52 Yes 0.52 0.3 0.36 29% No
Diphosphoglyceromutase (DPGM) 12 No 1.43 0.3 0.58 47% No
Several conditions have been identiﬁed that decrease the effectiveness of enzymes in the red blood cells. The effect of a reduction in the possible steady-state
ranges of ﬂuxes on the steady-state ﬂux space as a whole was simulated by decreasing themaximum allowable reaction ﬂux through the reaction catalyzed by the
given enzyme. The columns of the table show: 1), the enzyme defect being simulated; 2), the corresponding V imax; 3), whether the V
i
max is constraining on the
system; 4), the actual maximum ﬂux rate for the reaction in the network; 5), the actual minimum ﬂux rate (V imin) for the reaction in the network; 6), to what extent
V imax is restricted to constrain the allowable ﬂux range for the reaction to one-quarter of its original value; 7), the percentage drop in the volume of the steady-state
ﬂux space corresponding to the simulated enzymopathy; and 8), whether defects in an enzyme had been experimentally determined to cause anemia or not.
*Taken from Tanaka et al. (1990).
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It may prove to be true that ﬂuxes that are in improbable
regions are likely to require other factors than those modeled
(such as a high degree of regulation, or additional
physicochemical constraints) to maintain them in the
experimentally measured operating state of the cell.
The degree of dependence between all of the ﬂuxes in the
red blood cell metabolic network was determined by
calculating correlation coefﬁcients from the uniform random
samples. Different methods have been used to calculate
correlated subsets in a metabolic network, including extreme
pathway analysis (Papin et al., 2002; Price et al., 2002),
elementary mode analysis (Pfeiffer et al., 1999), and the
linear programming-based ﬂux-coupling ﬁnder (Burgard
et al., 2004). The correlated reaction subsets calculated by
extreme pathway and elementary modes correspond only to
sets that are perfectly correlated. The sets calculated using
the ﬂux-coupling ﬁnder (Burgard et al., 2004) are more
informative and scalable to larger networks. In contrast to
previous methods, the direct calculation of correlation
coefﬁcients from the Monte Carlo sampling procedure
allowed for the stratiﬁcation of pairwise correlations among
all ﬂuxes between 0 and 1 (r2ij) or between 1 and 1 (rij).
Thus, the unbiased degree of independence can be de-
termined for any two ﬂuxes under any set of conditions.
Experimental design can be guided from the results of
uniform random sampling within a constrained metabolic
solution space. Both the probability distributions and the
calculated correlation coefﬁcients are condition-dependent,
and thus change with the addition of more experimental data.
One implication of this fact is that it is best to include as
much known information as possible into the model before
sampling. Subsequently, the model predicts which combi-
nations of measurements provide independent information
and which ﬂuxes are correlated to the highest number of
FIGURE 3 Systemic effects of simulated enzymopathy in pyruvate kinase. Pyruvate kinase catalyzes the reaction from PEP to pyruvate. Using the Monte
Carlo sampling technique, the probability distribution of all ﬂuxes in the red blood cell were shown (solid line). The allowable range of the PK reaction was
decreased to 0.5 (dashed line) and 0.25 (dotted line) of its original range by decreasing its effective V imax. All of the curves were normalized such that the highest
point in each of the curves is the same. The actual volume of the steady-state ﬂux space being sampled and represented in each histogram is 6.83 105 (mM/
h)11 for the original solution space, 2.1 3 105 (mM/h)11 (31% of original space) for PK range decreased in one-half, and 5.6  107 (mM/h)11 (0.83% of
original solution space) for the PK range decreased to one-fourth. The effect of the simulated PK enzymopathy was different for different reactions, ranging
from virtually no change (NH3 exchange) to signiﬁcant shift in shape and magnitude (HK, PGK). Each distribution shown accounts for 100,000 uniformly
distributed points within the steady-state ﬂux space.
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TABLE 3 Change in ﬂux correlations for simulated PK enzymopathies
Difference between the new squared correlation coefﬁcient of the steady-state ﬂux space with the V imax of PK decreased so that the ﬂux range of PK was decreased to one-quarter of its initial range. The
correlation matrices for each case (full PK ﬂux range and one-quarter PK ﬂux range) were calculated using 1,000,000 uniformly random points in the steady-state ﬂux space. To give an indication of an error
in the estimates, the difference matrix was calculated twice from independent samples of 1,000,000 points each. The maximum change in any calculated difference as reported in this table was 0.002.
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other ﬂuxes under the studied conditions. Since the choice of
ﬂuxes to measure providing independent information can
change with the experimental conditions, it is important that
the Monte Carlo sampling procedure be used iteratively to
determine which ﬂux measurements are the most indepen-
dent at each step. Thus, following the results of one set of
experimental measurements, the sampling procedure can be
redone to reevaluate the most important measurements given
what is already known. Of course, those ﬂuxes that are
perfectly correlated (rij ¼ 1) will remain perfectly correlated,
regardless of condition. The volume of the solution spaces
also changes, giving a quantitative measure for how many
potential steady-state ﬂuxes are in agreement with the
measured data. As the volume of the steady-state ﬂux space
approaches zero, the internal ﬂux distribution inside a cell is
determined. Other constraint-based methods also exist for
guiding experimental design and could perhaps be used in
conjunction with the method proposed herein. One such
method enables the calculation of the optimal set of ﬂuxes to
measure to minimize the impact of experimental error on the
prediction of the steady-state ﬂux state (Savinell and Palsson,
1992a,b).
The effects of enzymopathies on the capabilities of
a metabolic network can be studied using the Monte Carlo
sampling procedure. Single nucleotide polymorphisms
(SNPs) or other genetic defects can impair enzyme function.
This impairment can be the result of such factors as an
enzyme having a lowered V imax or by a lower rate constant
which can effectively lower the allowable maximum ﬂux
based on the concentration of the substrates in the red blood
cell. Importantly, since the probability distributions of
individual ﬂuxes and the correlations between them change
under differing conditions, the Monte Carlo sampling
procedure can be used to study both normal and pathological
cases under a variety of different environments. Clinical
outcomes of enzymopathies can obviously involve a great
many factors outside of those modeled. However, model-
driven studies describe the impact of an enzymopathy on the
known metabolic network uncoupled from other consider-
ations. Thus, model-driven assessments provide evidence for
whether or not a metabolic explanation is sufﬁcient to
account for a clinical outcome or not. Indeed, the apparent
lack of an explanation for a clinical outcome based on what
is known about a metabolic network can lead to novel
biological understanding and provide a basis for novel
hypotheses. One example of this is the observation that the
maximal enzymatic activity of G6PDH vastly exceeds what
seems to be needed in the network (Salvador and Savageau,
2003).
Constraining the ﬂux range for the glycolytic enzymes
showed a general trend seen that those simulated enzymo-
pathies that severely restricted the steady-state ﬂux space
had been shown experimentally to cause anemia, whereas
those that were less restrictive did not (Table 2). The
exception to this trend was lactate dehydrogenase (LDH),
the inhibition of which greatly restricted the steady-state ﬂux
space, but which has not been found to lead to anemia
(Tanaka and Zerez, 1990). This may be because restriction
of LDH does not signiﬁcantly restrict the glycolytic rate,
since pyruvate can leave the cell as the endpoint of gly-
colysis. However, the restriction of LDH does affect the
cell’s ability to control NADH levels. Another observation
was that, although G6PDH is by far the most common
enzymopathy in the red blood cell, only a small fraction of
G6PDH enzymopathies lead to anemia. Although fewer in
number, a higher fraction of PK enzymopathies than G6PDH
enzymopathies lead to anemia. This fact may be attributable,
in part, to the fact that restricting PK is generally much
more constraining on the metabolism as a whole than is
G6PDH.
Strong similarities were seenwhen comparing the results of
the simulated enzymopathies with results from an interesting
earlier study using a full-scale kinetic model of glycolysis
(Holzhu¨tter et al., 1985). In Holzhu¨tter et al. (1985), a kinetic
model of glycolysis was used to study the impact of lowering
enzyme activity in a ‘‘metabolic homeostasis function.’’ Of
the reactions studied in Holzhu¨tter et al. (1985), one of them,
HK, was found using the Monte Carlo sampling procedure to
FIGURE 4 Effect of simulated enzymopathy
on correlation between other ﬂuxes in network.
Decreasing the maximum reaction rate of PK
decreases the number of valid steady-state
solutions. Solutions for the simulated PK
enzymopathy are a subset of those without the
simulated PK enzymopathy. Thus, the areas
under the curve as shown are not representative.
In each case, the size of the solution space with
the enzymopathy is 0.83% of the size of the
solution space without the enzymopathy. The
PK enzymopathy can increase or decrease the
correlation between sets of reactions. The
correlation between HK and G6PDH goes from
0.06 up to 0.85 when the range of PK values is
reduced to 25% (A), whereas the correlation between TPI and GAPDH decreased from 0.83 to 0.07 (B). The plots were generated using 300,000 uniformly
distributed points within the steady-state ﬂux space.
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have a right peak distribution, trailing off to zero probability
as the ﬂux level through this reaction decreased, and another
of the reactions, AK, was left peak, trailing off to zero
probability as the ﬂux level through this reaction increased.
The kinetic model predicted that constricting HK had the
most impact on the homeostasis of the red blood cell and that
restrictions of AK had the least, just as predicted with the
distributions givenwith theMonte Carlo sampling procedure.
The ﬂuxes shown by the kinetic model to have effects on
homeostasis between the extremes of HK and AK, all had
either central peak distributions, or were constrained such that
the difference in probabilities over the ﬂux range were not
highly variable, matching expectations from the sampling
procedure. Thus, results of the Monte Carlo sampling
procedure corresponded well to results from a kinetic model
which requires measurement of a large number of kinetic
enzyme data to formulate. The need for few kinetic
parameters becomes essential as the Monte Carlo sampling
procedure is applied to organisms where kinetic data is much
sparser than in the well-characterized red blood cell.
The uniform distribution of points within the solution
space used in this study is not meant to imply that the ﬂux
steady states of cells in a population are likewise distributed
uniformly within the range of allowable steady states.
Indeed, it seems highly unlikely that a population of cells
would be distributed uniformly in this manner, since certain
regions of the solution space are expected to be preferred or
excluded based on additional, unmodeled demands and
physicochemical constraints under which cells operate.
Rather, uniformity is used to clearly grasp the implications
of applying the physicochemical constraints to the recon-
structed metabolic network. Although not utilized for the
purposes of this study, the Monte Carlo sampling procedure
could potentially be used to study distributions of popula-
tions in cells. The informative aspect of such an approach
would be to see how the population density deviated from
a uniform distribution within the range of allowable steady
states for the in silico cell. By identifying which portions of
the steady-state ﬂux space were favored within the
population of cells, hypotheses for the preferred states could
be formed and the importance of additional physicochemical
constraints could be assessed.
Although the present study focused on studying the
steady-state ﬂux space, the approach detailed herein can be
equally well applied to study concentration or kinetic spaces
associated with a reconstructed biochemical network. Also
any additional physicochemical law can be used to further
conﬁne sets of candidate solutions. If the imposed constraints
can be represented as linear equations, they can be easily
implemented into this framework and, aside from computa-
tional limitations, uniform random sampling can easily be
done within the space. Once the set of candidate solutions
are generated, any type of nonlinear constraint, such as
stemming from regulation or thermodynamics, can be
applied as a postprocessing step (as long as dimensionality
of the space is not reduced) by eliminating candidate
solutions that do not satisfy the imposed constraint.
Although ‘‘elimination’’ algorithms such as the one used
in this study have certain advantages for sampling smaller
networks, it is likely that any ‘‘elimination’’ approach to
sampling will be inadequate for sampling genome-scale
networks. This difﬁculty in generating samples in high-
dimensional objects occurs because the ratio of the size of an
enclosing object to the size of the enclosed object increases
rapidly as dimension increases. However, genome-scale
networks can be sampled (Almaas et al., 2004) using
alternate, but similar, methods for generating the set of
candidate solutions, such as Monte Carlo Markov-chain
samplers (Chen and Schmeiser, 1993; Kaufman and Smith,
1998; Lovasz, 1999; Zabinsky et al., 1993), and such
methods have been well studied and continue to improve.
Thus, the methods described herein for analyzing uniform
random samples from solution spaces can be utilized for
studying genome-scale networks.
Taken together, uniform random sampling provides a
broadening of the constraint-based approach by allowing
for the unbiased and detailed assessment of the capabilities
of reconstructed networks subject to the imposition of
physicochemical constraints. Uniform random sampling of
solution spaces allows for a detailed framework in which to
design experiments to determine the operating state of the
cell, a context in which to study the resulting experimental
data, as well as detailed insight into what network behaviors
are allowed by the imposition of the stated constraints upon
the reconstructed network. Clearly understanding model
predictions is important because a cell-scale model provides
the most compact and quantitative representation of a large-
scale hypothesis of how a cell works. Thus, the Monte Carlo
sampling procedure coupled with ongoing network re-
construction provides a powerful engine to drive experi-
mental work and the iterative model-building process that is
at the heart of systems biology.
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TABLE 5 Reactions
Abbreviation Enzyme Chemical reaction
Glycolysis and Rapoport-Leubering shunt
HK Hexokinase GLU1 ATP/ G6P1 ADP
1 H
PGI Phosphoglucoisomerase G6P4 F6P
PFK Phosphofructokinase F6P 1 ATP/ FDP 1 ADP
1 H
ALD Aldolase FDP4 GA3P 1 DHAP
TPI Triose phosphate isomerase DHAP4 GA3P
GAPDH Glyceraldehyde phosphate
dehydrogenase
GA3P 1 NAD 1 Pi 4
13DPG 1 NADH 1 H
PGK Phosphoglycerate kinase 13DPG 1 ADP4 3PG
1 ATP
DPGM Diphosphoglyceromutase 13DPG 1/ 23DPG 1 H
DPGase Diphosphoglycerate
phosphatase
23DPG 1 H2O/ 3PG 1 Pi
PGM Phosphoglyceromutase 3PG4 2PG
EN Enolase 2PG4 PEP 1 H2O
PK Pyruvate kinase PEP 1 ADP 1 H/ PYR
1 ATP
LDH Lactate dehydrogenase PYR 1 NADH 1 H4 LAC
1 NAD
Pentose phosphate pathway
G6PDH Glucose-6-phosphate
dehydrogenase
G6P 1 NADP/ 6PGL
1 NADPH 1 H
PGL 6-phosphoglyconolactonase 6PGL 1 H2O4 6PGC 1 H
PDGH 6-phosphoglycoconate
dehydrogenase
6PGC 1 NADP/ RL5P
1 NADPH 1 CO2
R5PI Ribose-5-phosphate
isomerase
RL5P4 R5P
Xu5PE Xylulose-5-phosphate
epimerase
RL5P4 X5P
TKI Transketolase I X5P 1 R5P4 S7P 1 GA3P
TA Transaldolase GA3P 1 S7P4 E4P
1 GA3P
TKII Transketolase II X5P 1 E4P4 F6P 1 GA3P
Adenosine nucleotide metabolism
PRPPsyn Phosphoribosyl
pyrophosphate synthetase
R5P 1 ATP/ PRPP
1 AMP
PRM Phosphoribomutase R1P4 R5P
HGPRT Hypoxanthine guanine
phosphoryl transferase
PRPP 1 HX 1 H2O/ IMP
1 2Pi
AdPRT Adenine phosphoribosyl
transferase
PRPP 1 ADE 1 H2O/
AMP 1 2Pi
PNPase Purine nucleoside
phosphorylase
INO 1 Pi4 HX 1 R1P
IMPase Inosine monophosphatase IMP 1 H2O/ ADO 1 Pi
1 H
AMPDA Adenosine monophosphate
deaminase
AMP 1 H2O/ IMP 1 NH3
AMPase Adenosine monophosphate
phosphohydrolase
AMP 1 H2O/ ADO
1 NH3
ADA Adenosine deaminase ADO1 H2O/ INO1 NH3
AK Adenosine kinase ADO 1 AMP/ ADP
1 AMP
ApK Adenylate kinase 2ADP4 ATP 1 AMP
TABLE 4 Metabolites
Abbreviation Metabolite
GLC Glucose
G6P Glucose-6-phosphate
F6P Fructose-6-phosphate
FDP Fructose-1,6-diphosphate
DHAP Dihydroxyacetone phosphate
GA3P Glyceraldehyde-3-phosphate
13DPG 1,3-Diphosphoglycerate
23DPG 2,3-Diphosphoglycerate
3PG 3-Phosphoglycerate
2PG 2-Phosphoglycerate
PEP Phosphoenolpyruvate
PYR Pyruvate
LAC Lactate
6PGL 6-Phosphogluco-lactone
6PGC 6-Phosphogluconate
RL5P Ribulose-5-phosphate
X5P Xylulose-5-phosphate
R5P Ribose-5-phosphate
S7P Sedoheptulose-7-phosphate
E4P Erythrose-4-phosphate
PRPP 5-Phosphoribosyl-1-pyrophosphate
IMP Inosine monophosphate
R1P Ribose-1-phosphate
HX Hypoxanthine
INO Inosine
ADE Adenine
ADO Adenosine
AMP Adenosine monophosphate
ADP Adenosine diphosphate
ATP Adenosine triphosphate
NAD Nicotinamide adenine dinucleotide
NADH Nicotinamide adenine dinucleotide (R)
NADP Nicotinamide adenine dinucleotide phosphate
NADPH Nicotinamide adenine dinucleotide phosphate (R)
H Hydrogen ion
Pi Inorganic phosphate
NH3 Ammonia
CO2 Carbon dioxide
H2O Water
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